Given the known relationship between ADM and the progression of metastatic cancers, as well as the known tumor suppressor function of E-cadherin in other tissues, pathogenic E-cadherin inactivation may be sufficient to initiate pancreatic cancer. This evidence concerns the gene CDH1 and metastatic malignant neoplasm.